CN109678951A - 在亲和层析纯化中减少抗体多聚的方法 - Google Patents
在亲和层析纯化中减少抗体多聚的方法 Download PDFInfo
- Publication number
- CN109678951A CN109678951A CN201811606430.2A CN201811606430A CN109678951A CN 109678951 A CN109678951 A CN 109678951A CN 201811606430 A CN201811606430 A CN 201811606430A CN 109678951 A CN109678951 A CN 109678951A
- Authority
- CN
- China
- Prior art keywords
- balance
- arginine
- buffer
- elution
- chromatographic column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
Abstract
Description
平衡1 | 0.1M Tris-HCl,pH 7.0 |
冲洗缓冲液 | 600mM Arginine pH 8.0 |
平衡2 | 0.1M Tris-HCl,pH 7.0 |
洗脱缓冲液 | 0.1M Glycine,pH 3.5,0.2M Arginine |
清洁缓冲液 | 100mM Phosphoric acid |
平衡3 | 0.1M Tris-HCl,pH 7.0 |
再生缓冲液 | 0.5M NaOH |
平衡4 | 0.1M Tris-HCl,pH 7.0 |
保存液 | 20%(v/v)ethanol |
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811606430.2A CN109678951A (zh) | 2018-12-27 | 2018-12-27 | 在亲和层析纯化中减少抗体多聚的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811606430.2A CN109678951A (zh) | 2018-12-27 | 2018-12-27 | 在亲和层析纯化中减少抗体多聚的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109678951A true CN109678951A (zh) | 2019-04-26 |
Family
ID=66189878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811606430.2A Pending CN109678951A (zh) | 2018-12-27 | 2018-12-27 | 在亲和层析纯化中减少抗体多聚的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109678951A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110204612A (zh) * | 2019-05-29 | 2019-09-06 | 上海药明生物技术有限公司 | 采用Protein A亲和层析纯化纳米抗体药物的方法 |
CN112522317A (zh) * | 2020-12-29 | 2021-03-19 | 北京百普赛斯生物科技股份有限公司 | 提高真核表达系统表达的ace2蛋白稳定性的方法 |
CN112898413A (zh) * | 2021-04-07 | 2021-06-04 | 杭州奕安济世生物药业有限公司 | 采用亲和层析纯化减少抗体聚集的方法 |
CN113845561A (zh) * | 2020-06-28 | 2021-12-28 | 佛山汉腾生物科技有限公司 | 目的蛋白纯化方法 |
CN113980092A (zh) * | 2021-12-09 | 2022-01-28 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
CN114539417A (zh) * | 2020-11-26 | 2022-05-27 | 盛禾(中国)生物制药有限公司 | 一种有效去除双特异性抗体同源二聚体的层析纯化工艺 |
CN116425864A (zh) * | 2023-02-22 | 2023-07-14 | 北京东方略生物医药科技股份有限公司 | 一种IgM抗体纯化方法 |
WO2024009279A1 (en) * | 2022-07-07 | 2024-01-11 | Takeda Pharmaceutical Company Limited | Affinity chromatography using an elution buffer comprising glycine and arginine |
CN113980092B (zh) * | 2021-12-09 | 2024-05-14 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105017418A (zh) * | 2014-03-27 | 2015-11-04 | 上海药明康德新药开发有限公司 | 单克隆抗体纯化工艺方法 |
CN105273041A (zh) * | 2014-07-08 | 2016-01-27 | 上海中信国健药业股份有限公司 | 一种蛋白质亲和层析洗脱方法 |
-
2018
- 2018-12-27 CN CN201811606430.2A patent/CN109678951A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105017418A (zh) * | 2014-03-27 | 2015-11-04 | 上海药明康德新药开发有限公司 | 单克隆抗体纯化工艺方法 |
CN105273041A (zh) * | 2014-07-08 | 2016-01-27 | 上海中信国健药业股份有限公司 | 一种蛋白质亲和层析洗脱方法 |
Non-Patent Citations (1)
Title |
---|
颜真等: "《蛋白质研究技术》", 31 January 2007, 第四军医大学出版社 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110204612A (zh) * | 2019-05-29 | 2019-09-06 | 上海药明生物技术有限公司 | 采用Protein A亲和层析纯化纳米抗体药物的方法 |
CN113845561A (zh) * | 2020-06-28 | 2021-12-28 | 佛山汉腾生物科技有限公司 | 目的蛋白纯化方法 |
CN114539417A (zh) * | 2020-11-26 | 2022-05-27 | 盛禾(中国)生物制药有限公司 | 一种有效去除双特异性抗体同源二聚体的层析纯化工艺 |
CN112522317A (zh) * | 2020-12-29 | 2021-03-19 | 北京百普赛斯生物科技股份有限公司 | 提高真核表达系统表达的ace2蛋白稳定性的方法 |
CN112898413A (zh) * | 2021-04-07 | 2021-06-04 | 杭州奕安济世生物药业有限公司 | 采用亲和层析纯化减少抗体聚集的方法 |
CN113980092A (zh) * | 2021-12-09 | 2022-01-28 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
CN113980092B (zh) * | 2021-12-09 | 2024-05-14 | 上海药明生物技术有限公司 | 一种蛋白质亲和纯化方法 |
WO2024009279A1 (en) * | 2022-07-07 | 2024-01-11 | Takeda Pharmaceutical Company Limited | Affinity chromatography using an elution buffer comprising glycine and arginine |
CN116425864A (zh) * | 2023-02-22 | 2023-07-14 | 北京东方略生物医药科技股份有限公司 | 一种IgM抗体纯化方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109678951A (zh) | 在亲和层析纯化中减少抗体多聚的方法 | |
Chollangi et al. | Development of robust antibody purification by optimizing protein‐A chromatography in combination with precipitation methodologies | |
EP3040346B1 (en) | Process for the purification of granulocyte colony stimulating factor, g-csf | |
CN104059133B (zh) | 一类突变的具有高耐碱特性的蛋白a及其应用 | |
RU2009106083A (ru) | Аргининовая промывка для очистки белков с использованием аффинной хроматографии | |
EP3247718B1 (en) | Modulation of charge variants in a monoclonal antibody composition | |
EP3436473A1 (en) | A process for purification of fc-fusion proteins | |
US20130178608A1 (en) | Protein purification by ion exchange | |
Geiser et al. | In-line system containing porous polymer monoliths for protein digestion with immobilized pepsin, peptide preconcentration and nano-liquid chromatography separation coupled to electrospray ionization mass spectroscopy | |
Bhambure et al. | A novel multimodal chromatography based single step purification process for efficient manufacturing of an E. coli based biotherapeutic protein product | |
JPWO2011162210A1 (ja) | アミノ酸を利用したタンパク質の精製方法 | |
JP3894570B2 (ja) | Igf−iの精製方法 | |
WO2019184368A1 (zh) | 一种高纯度rhNGF的制备方法 | |
KR20170026521A (ko) | 단백질의 정제를 위한 방법 및 시약 | |
AU2015248461B2 (en) | Novel purification process of gonadotropin | |
CN110066314A (zh) | 一种高效提高多聚体分离分辨率的亲和纯化工艺 | |
CN108101959B (zh) | 一种制备高纯度多肽或其类似物的方法 | |
EP1444249B1 (en) | Method of protein purification | |
CN113061152B (zh) | 一种利用氨基型树脂分离纯化甘油葡萄糖苷的方法 | |
JP6232130B2 (ja) | ダルベポエチンアルファの精製方法 | |
CN102876645A (zh) | 双功能色谱介质辅助溶菌酶体外复性的方法 | |
CN109324143B (zh) | 利用二维液相分离制备抗体类产品相关杂质的方法 | |
JP2021535214A (ja) | インスリンアナログの精製のためのクロマトグラフィープロセス | |
Iberg et al. | The Use of Heparin Affinity High-Performance Liquid Chromatography for the Isolation and Characterization of Fibroblast Growth Factors | |
AU2013203253B2 (en) | Process for the purification of a growth factor protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200103 Address after: 200131 A location of 301 parts of 2 building, 299 Fu Tai Road, Pudong New Area Free Trade Zone, Shanghai Applicant after: WUXI BIOLOGICS (SHANGHAI) Co.,Ltd. Applicant after: Wuxi Yaoming coupling Biotechnology Co.,Ltd. Applicant after: Wuxi Yaoming Biotechnology Co.,Ltd. Address before: 200131 A location of 301 parts of 2 building, 299 Fu Tai Road, Pudong New Area Free Trade Zone, Shanghai Applicant before: WUXI BIOLOGICS (SHANGHAI) Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 200131 Shanghai Pudong New Area pilot Free Trade Zone Applicant after: WUXI BIOLOGICS (SHANGHAI) Co.,Ltd. Applicant after: Wuxi Yaoming United Biotechnology Co.,Ltd. Applicant after: Wuxi Yaoming Biotechnology Co.,Ltd. Address before: 200131 Shanghai Pudong New Area pilot Free Trade Zone Applicant before: WUXI BIOLOGICS (SHANGHAI) Co.,Ltd. Applicant before: Wuxi Yaoming coupling Biotechnology Co.,Ltd. Applicant before: Wuxi Yaoming Biotechnology Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190426 |